Sort
30,917 grants matching “tumor microenvironment”
NOX family NADPH oxidases: roles in innate immunity and inflammatory disease
$761,504Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Quantitative imaging phenotypic classifier for distinguishing radiation effects from tumor recurrence in Glioblastoma
$761,344Pallavi Tiwari · University Of Wisconsin-Madison · R01 · FY2023 · CA
Southwest Early Clinical Trials - Phase 2 Consortium
$759,923Funda Meric-Bernstam · University Of Tx Md Anderson Can Ctr · UM1 · FY2016 · CA
Novel Markers for Disease Outcome in Breast Cancer
$759,873Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Evaluation of an implantable microdevice for rapid cancer drug screening directly in T cell lymphoma patients
$759,496Cecilia Larocca · Brigham And Women'S Hospital · R37 · FY2020 · CA
Clinical Translation of a Novel Diagnostic Agent to Predict Immunotherapy Response in Solid Tumors
$759,285James F Kronauge · Cytosite Biopharma, Inc. · R44 · FY2019 · CA
Development of TGF-beta antagonists for cancer therapy
$758,999Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy
$758,985Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · CA
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy
$758,985Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · CA
Coordinating and Data Management Center for Acquired Resistance to Therapy Network
$758,183Alan David Hutson · Roswell Park Cancer Institute Corp · U24 · FY2024 · CA
Role of the microenvironment in regulating early stages of thymic involution and central tolerance
$757,731Lauren Ilyse Richie Ehrlich · University Of Arizona · P01 · FY2024 · AG
Colorectal carcinogenesis and Fusobacterium nucleatum: oncomicrobe, oncometabolites, and oncoimmunology
$757,626Wendy S. Garrett · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2025 · CA
The Molecular Profile of Prostate Tumors in African-American Men
$757,524Stefan Ambs · Basic Sciences · Z01 · FY2007 · CA
Fibroblast Heterogeneity in Pancreatic Cancer
$756,549David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2024 · CA
New approach for immune modulation against T1D
$756,491Weston Daniel · Evoq Therapeutics, Inc. · R44 · FY2024 · DK
Biostatistics Core
$756,209Peter A Jones · University Of Southern California · P30 · FY2014 · CA
ECM geometrical and mechanical properties modulate RTK signaling
$756,191Jay T. Groves · University Of California Berkeley · U01 · FY2017 · CA
Zebrafish core
$756,150Christine Kettenhofen · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
Biostatistics Core
$755,906Peter A Jones · University Of Southern California · P30 · FY2015 · CA
Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response
$755,852Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Zebrafish core
$755,762Christine Kettenhofen · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
CLINICAL THERAPY TRIALS
$755,312Katherine Kurshan Matthay · Children'S Hospital Of Los Angeles · P01 · FY2009 · CA
Mechanisms and Optimal Combinations of Cisplatin Chemotherapy for Head and Neck Squamous Cell Carcinoma
$754,861Nicole Schmitt · National Institute On Deafness And Other Communication Disorders · ZIA · FY2016 · DC
Targeting Stoma-Tumor Co-Dependency for Glioma Therapy
$754,845David H. Gutmann · Washington University · U01 · FY2012 · CA
Hydrogel microparticle technology for high-throughout screening of chimeric antigen receptor-T cells based on single cell effector function
$754,792Joseph De Rutte · Partillion Bioscience Corporation · R44 · FY2023 · GM